← Open Payments lookup

ERIN KERSHISNIK: Open Payments

NPI 1861584161 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$386 in 30 payments from 9 companies in 2025. Trend: 2023 $273 · 2024 $143 · 2025 $386

Food & beverage: $386
CompanyPaymentsAmount
ABBVIE INC.18$171
Phathom Pharmaceuticals, Inc.2$56
Takeda Pharmaceuticals U.S.A., Inc.2$37
PFIZER INC.2$30
AstraZeneca Pharmaceuticals LP2$29
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$17
Boehringer Ingelheim Pharmaceuticals, Inc.1$16
Exact Sciences Corporation1$16
Lilly USA, LLC1$14

Products named: QULIPTA, UBRELVY, VOQUEZNA, TRINTELLIX, PAXLOVID, AIRSUPRA, XIFAXAN, JARDIANCE.

Industry payments across WA — which companies pay providers there.